In-vitro Diagnostic Services Market
In-vitro Diagnostic Services Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
In-vitro Diagnostic Services Market Size and Growth
The global in-vitro diagnostic services market is projected to reach $98.2 billion by 2028, growing at a CAGR of 5.4%. The market is driven by rising demand for early disease diagnosis, growing geriatric population, and technological advancements in diagnostic tools. Key players include Roche Diagnostics, Siemens Healthineers, and Abbott Laboratories.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ BioRad
◍ DexCom
◍ Nova Biomedical
◍ OraSure
◍ Pearl Pathways
◍ Phenomenex
◍ Qiagen
◍ Roche Diagnostics
◍ Siemens
◍ Sysmex
◍ Thermofisher
The competitive landscape of the In-vitro Diagnostic Services Market includes companies such as BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche Diagnostics, Siemens, Sysmex, and Thermofisher. These companies offer a range of diagnostic services, instruments, and consumables that help in disease diagnosis and monitoring. Sales revenue figures for a few companies include Roche Diagnostics ($51 billion), Siemens ($16 billion), and Qiagen ($1.5 billion).
Request Sample Report
Market Segmentation
By Application By Product
◍ Hospitals
◍ Point-Of-Care Testing
◍ Laboratories
◍ Academic Institutes
◍ Infectious Testing ◍ Diabetes Testing ◍ Molecular Testing ◍ Tissue Testing
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
